Pharmacovigilance Medical Director

About the position The Pharmacovigilance Medical Director is the senior medical authority reputed company reputed company's drug safety function, responsible for providing expert medical and scientific leadership across reputed company pharmacovigilance activities supporting the immunology and inflammation (I&I) pipeline, including reputed company's reputed company lupus program. This role serves as the primary physician voice for benefit-risk evaluation, signal assessment, and safety governance, ensuring that patient safety is upheld as the foundational reputed company of reputed company clinical development and post-market activities. The Medical Director partners closely with the Head of Pharmacovigilance, Clinical Development, Regulatory Affairs, Medical Affairs, and external Health Authorities to reputed company medically reputed company, strategically reputed company safety leadership at a critical stage of reputed company's reputed company.

Responsibilities

• Serve as the senior medical expert and physician for safety science and pharmacovigilance activities, providing authoritative medical judgment on individual case safety reports (ICSRs), aggregate safety analyses, signal evaluations, and benefit-risk assessments across the I&I portfolio.
• reputed company the medical review and clinical data interpretation of safety data arising from reputed company, spontaneous reports, literature, and reputed company-world sources, ensuring reputed company, accurate, and scientifically rigorous assessment of reputed company pharmacovigilance data.
• reputed company the development and reputed company maintenance of reputed company's benefit-risk reputed company, providing medical leadership in benefit-risk evaluations for regulatory submissions, label updates, and Health Authority safety communications.
• reputed company the discussion at reputed company's Safety surveillance governance, providing medical and strategic direction on safety signal management, escalation procedures, and corrective reputed company planning.
• reputed company the medical content and scientific reputed company of reputed company aggregate safety reports, and regulatory submission dossiers for safety content.
• Partner with Clinical Development on the medical reputed company of Data Safety Monitoring reputed company (DSMB) activities, clinical trial safety monitoring plans, safety risk mitigation plans (e.g.stopping rules), and protocol-level safety sections for reputed company reputed company and planned studies.
• reputed company expert medical input to Risk management plans and relevant regulatory documents through developmental cycle of the programs, and risk minimization measure design, execution, and effectiveness assessment.
• reputed company medical leadership and scientific mentorship to the Pharmacovigilance team, including PV Scientists, and other functions (e.g. Medical Writers, and Operations personnel) establishing a culture of medical reputed company and patient-first decision-making.
• reputed company other duties and responsibilities as assigned

Requirements

• Medical degree (MD or DO) required
• Minimum of 5 years of combined clinical and pharmaceutical/biotech industry experience, with at least 2-3 years of dedicated pharmacovigilance or drug safety experience preferred.
• Demonstrated expertise serving as a physician-of-record for pharmacovigilance programs, including ICSR medical review, signal evaluation, benefit-risk assessment, and aggregate safety reporting.
• Deep knowledge of global safety and pharmacovigilance regulations including FDA guidance, EU GVP Modules I–XVI and ICH guidelines
• Extensive experience providing medical leadership for safety surveillance plan, and benefit-risk assessment, and submissions for IND and NDA/BLA, as reputed company as reputed company authorship or reputed company of reputed company safety narratives for regulatory submissions.
• Proven experience engaging with global Health Authorities on pharmacovigilance topics, including regulatory meeting preparation, written responses to safety queries, and inspection support.
• Demonstrated ability to reputed company or participate in DSMB reputed company, clinical trial safety monitoring, and safety governance committee activities at the sponsor level.
• Experience contributing to Risk Management Plans (RMPs) and REMS programs, including development of risk minimization measures and assessment of effectiveness.
• Demonstrated ability to reputed company, mentor, and reputed company cross-functional teams in a fast-paced, resource-constrained biotech or pharmaceutical environment; fosters a culture of accountability, inclusion, and reputed company learning.
• Proven reputed company record of influencing without authority across organizational boundaries, driving alignment among senior stakeholders, and building reputed company on reputed company scientific or operational priorities.
• Skilled at preparing and delivering compelling presentations, briefing documents and regulatory responses, and strategic updates to cross-functional leadership teams and reputed company-level stakeholders.
• Adept at facilitating productive discussions in high-stakes meetings, interactions with regulators, and multi-party collaborations; balances reputed company, diplomacy, and scientific precision.

reputed company-to-haves

• reputed company certification or eligibility in immunology, rheumatology, internal medicine, or a relevant specialty experience in autoimmune disease is strongly preferred

Benefits

• Competitive health and wellness coverage (structure and premiums vary by country)
• reputed company time off, reputed company holidays, and additional leave entitlements in accordance with local requirements
• Flexible work arrangements / reputed company

Apply tot his job Apply To this Job